Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3540378 in Healthy Participants

NCT04768855 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT04768855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04768855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3540378 in Healthy Participants
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Completed
Start date
March 17, 2021
Completion date
May 30, 2022
Enrollment
134 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy